Chronic daily headache with medication overuse: A randomized follow-up by neurologist or PCP

Cephalalgia

Volumn 29, Issue 8, 2009, Pages 855-863

  Bøe, Mg ^a,f   Salvesen, R ^b,c   Mygland, A ^a,d,e  

^a Department of Neurology   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c NORDLAND HOSPITAL   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

^e UNIVERSITY OF BERGEN   (Norway)

^f Neurological Department   (Norway)

Author keywords

Medication overuse headache; Primary care physician; Withdrawal

Indexed keywords

CODEINE; ERGOT DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENAZONE; PLACEBO; PREDNISOLONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE;

ADULT; ANXIETY; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; MIGRAINE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTCOME ASSESSMENT; PHYSICIAN; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; TENSION HEADACHE;

ADULT; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HEADACHE DISORDERS; HUMANS; MALE; MIDDLE AGED; NEUROLOGY; NORWAY; PAIN MEASUREMENT; PATIENT SATISFACTION; PHYSICIANS, FAMILY; PREVALENCE; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; WITHHOLDING TREATMENT;

EID: 65449152400     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01810.x     Document Type: Article

References (23)

1. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol 2004 3 : 475 83.
2. Clinical DW. Dodick practice. Chronic daily headache. N Engl J Med 2006 354 : 158 65.
3. Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001 57 : 1694 8.
4. Linton-Dahlof P, Linde M, Dahlof C. Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia 2000 20 : 658 62.
5. Hu XH, O'Donnell F, Kunkel RS, Gerard G, Markson LE, Berger ML. Survey of migraineurs referred to headache specialists: care, satisfaction, and outcomes. Neurology 2000 55 : 141 3.
6. Bekkelund SI, Salvesen R. Patient satisfaction with a neurological specialist consultation for headache. Scand J Prim Health Care 2002 20 : 157 60.
7. Walling AD, Woolley DC, Molgaard C, Kallail KJ. Patient satisfaction with migraine management by family physicians. J Am Board Fam Pract 2005 18 : 563 6.
8. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 2004 24 (Suppl. 1 9 160.
9. Mykletun A, Stordal E, Dahl AA. Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry 2001 179 : 540 4.
10. Olsson I, Mykletun A, Dahl AA. The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 2005 5 : 46.
11. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979 134 : 382 9.
12. Boe MG, Mygland A, Salvesen R. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology 2007 69 : 26 31. (Pubitemid 47025201)
13. Couch JR, Ziegler DK, Hassanein R. Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant effects. Neurology 1976 26 : 121 7.
14. Couch JR, Hassanein RS. Amitriptyline in migraine prophylaxis. Arch Neurol 1979 36 : 695 9.
15. Freitag FG, Lake A III., Lipton R, Cady R, Diamond S, Silberstein S. Inpatient treatment of headache: an evidence-based assessment. Headache 2004 44 : 342 60.
16. Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006 26 : 1097 105.
17. Fritsche G, Eberl A, Katsarava Z, Limmroth V, Diener HC. Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol 2001 45 : 229 35.
18. Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G. Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 2003 60 : 1682 3.
19. Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005 25 : 12 15. (Pubitemid 40143787)
20. Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health 1992 46 : 443 6.
21. Rasmussen BK. Epidemiology and socio-economic impact of headache. Cephalalgia 1999 19 (Suppl. 25 20 3.
22. Fiane I, Haugland ME, Stovner LJ, Zwart JA, Bovim G, Hagen K. Sick leave is related to frequencies of migraine and non-migrainous headache - the HUNT Study. Cephalalgia 2006 26 : 960 7.
23. Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007 27 : 193 210. (Pubitemid 46354128)